Cite

    Azaro, A., Ghiglione, L., Valdivia, C., Munné, M., Renedo, B., Sabaté, N., Alcalde, M., Braña, I., Hierro, C., Martin-Liberal, J., Ochoa de Olza, M., Argiles Martínez, G., Vilaró, M., Tabernero, J., & Rodon, J. (n.d.). early interventions to detect potential drug–drug interactions on patient eligibility for phase 1 clinical trials. European journal of cancer, 69, S42–. http://access.bl.uk/ark:/81055/vdc_100039473340.0x000017